NCT05673174

Brief Summary

The purpose of this study is to document the utility of the Vivio System in quantifying LVDP in healthy volunteers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
321

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 16, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 21, 2022

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 6, 2023

Completed
Last Updated

January 6, 2023

Status Verified

November 1, 2022

Enrollment Period

3 months

First QC Date

December 21, 2022

Last Update Submit

December 21, 2022

Conditions

Keywords

left ventricular diastolic pressure

Outcome Measures

Primary Outcomes (1)

  • To construct an algorithm from training data set to be used to estimate the ROC curve from the algorithm for a separate test data set.

    3 months

Interventions

Modified blood pressure cuff used to detect arterial waveforms used for the estimation of LVDP

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy Volunteers, no history of Heart Disease.

You may qualify if:

  • Adult subjects \>21 years of age.
  • No known significant health problems.
  • Willing and able to participate in all study evaluations.
  • Ability to understand and sign informed consent.

You may not qualify if:

  • Open skin lesions at the site of Vivio application / examination.
  • Inability to obtain brachial artery blood pressure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Avicena

Pasadena, California, 91105, United States

Location

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 21, 2022

First Posted

January 6, 2023

Study Start

June 16, 2022

Primary Completion

August 30, 2022

Study Completion

August 30, 2022

Last Updated

January 6, 2023

Record last verified: 2022-11

Locations